Calendar Adocia

Equities

ADOC

FR0011184241

Real-time Euronext Paris 02:02:47 29/04/2024 pm IST 5-day change 1st Jan Change
8.46 EUR +0.36% Intraday chart for Adocia -2.53% -26.69%

Chart calendar Adocia

f774e0e.ZjUKrPtM8Q3cdvuBxopU59JgSOinjLotXadFk_5Dseo.Igcn5so8k0WIBKG3kvJkopQjOt_L_It3aOR22I1y4bgTDVrmyQule5EDmA~bc37e7a84dd055cf317f103889453c3e

Upcoming events on Adocia

13/05/2024 Equity Spring Forum
14/05/2024 Q1 2024 Sales and Revenue Release
13/06/2024 Annual General Meeting
24/07/2024 Q2 2024 Sales and Revenue Release
19/09/2024 Q2 2024 Earnings Release
22/10/2024 Q3 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Sales and Revenue Release
13/03/2025 Q4 2024 Earnings Release (Projected)
22/09/2025 Q2 2025 Earnings Release (Projected)
21/09/2026 Q2 2026 Earnings Release (Projected)

Past events on Adocia

Today LSX World Congress
24/04/2024 09:30 pm Q4 2023 Earnings Release
09/04/2024 Mediterranean Cell & Gene Meeting
04/04/2024 Investor Access Conference
19/03/2024 Society Francophone Diabetes Congress
18/03/2024 BioEurope Spring Conference
17/03/2024 Roth Conference
28/02/2024 10:30 pm Q4 2023 Sales and Revenue Call
27/02/2024 10:30 pm Q4 2023 Sales and Revenue Release
28/10/2023 11:30 pm IPITA, IXA and CTRMS Meeting
25/10/2023 09:30 pm Q3 2023 Sales and Revenue Release
25/10/2023 09:30 pm Q3 2023 Earnings Release
05/10/2023 08:15 pm European Association for the Study of Diabetes Meeting
18/09/2023 09:30 pm Q2 2023 Earnings Release
26/07/2023 03:31 am Q2 2023 Sales and Revenue Release
24/06/2023 02:30 am Scientific Sessions of American Diabetes Association Meeting
11/05/2023 01:30 pm Annual General Meeting
25/04/2023 09:30 pm Q1 2023 Sales and Revenue Release
15/03/2023 10:30 pm Q4 2022 Earnings Release
10/01/2023 Biotech Showcase

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR
Released
Forecast
Spread
53,9
44,1
22.43%
8,13
8,80
-7.57%
6,83
5,13
33.17%
6,06
19,6
-69.04%
17,4
31,0
-43.92%
6,05
18,7
-67.66%
EBITDA
Million EUR
Released
Forecast
Spread
10,8
3,75
186.69%
-20,9
-29,7
29.76%
-20,0
3,60
-655.97%
0,00
0,00
-
0,00
3,10
-
0,00
10,3
-
EBIT
Million EUR
Released
Forecast
Spread
9,71
6,60
47.08%
-22,0
-30,0
26.6%
-21,1
-13,0
-62.8%
-19,4
-11,4
-70.48%
-12,9
-4,53
-184.4%
-14,2
9,60
-248.38%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-23,3
-13,4
-73.93%
-22,8
-13,2
-72.86%
-6,43
-13,3
51.78%
0,00
0,00
-
Net income
Million EUR
Released
Forecast
Spread
7,62
-0,63
1302.37%
-18,6
-22,0
15.44%
-23,3
-21,9
-6.75%
-22,8
-13,2
-72.86%
-6,90
-14,1
51.06%
-21,2
14,6
-244.95%
EPS
EUR
Released
Forecast
Spread
1,00
-0,26
492.16%
-2,70
-3,17
14.83%
-3,30
-2,25
-46.67%
-3,20
0,00
-
-0,90
-1,86
51.48%
0,00
2,05
-
Announcement Date12/03/1912/03/2018/03/2119/04/2215/03/2324/04/24

Quarterly results

Fiscal PeriodDecember 2019 S1 2020 S2 2021 Q2 2021 S1 2021 Q3 2021 Q4 2022 S1 2022 Q3 2022 Q4 2022 S2
Net sales
Million EUR
Released
Forecast
Spread
1,71


3,26
1,60
103.81%
0,29
16,5
-98.26%
0,40
16,6
-97.58%
1,76
1,50
17.33%

16,5

7,35



7,00


1,50

10,0
8,50
17.79%
EBIT
Million EUR
Released
Forecast
Spread






-4,82
8,00
-160.25%



-4,86
-7,50
35.2%
-4,86
6,75
-172%







-11,2




Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread






-5,30
7,94
-166.79%



-6,08
-7,69
20.91%
-6,08
6,32
-196.25%







-12,0




Net income
Million EUR
Released
Forecast
Spread
-13,0





-5,30
7,94
-166.79%



-6,08
-7,69
20.91%
-6,08
6,32
-196.25%
4,25






-12,0




EPS
EUR
Released
Forecast
Spread












-0,86
-0,92
6.52%










-1,43

-1,40
-2,16
35.19%
Announcement Date17/07/1918/03/2122/07/2122/07/2127/04/2219/04/2219/09/22--15/03/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise